Old Web
English
Sign In
Acemap
>
authorDetail
>
Gabriela Alperovich
Gabriela Alperovich
AbbVie
Medicine
Internal medicine
Risankizumab
Placebo
Family medicine
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis.
2021
Journal of Dermatological Treatment
Andrew Blauvelt
Kenneth B. Gordon
Patricia C. Lee
Jerry Bagel
Howard Sofen
Benjamin Lockshin
Ahmed M. Soliman
Ziqian Geng
Tianyu Zhan
Gabriela Alperovich
Linda Stein Gold
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial.
2021
Annals of the Rheumatic Diseases
Andrew J. K. Östör
Filip Van den Bosch
Kim A. Papp
Cecilia Asnal
Ricardo Blanco
Jacob A. Aelion
Gabriela Alperovich
Wenjing Lu
Zailong Wang
Ahmed M. Soliman
Ann Eldred
Lisa Barcomb
Alan Kivitz
Show All
Source
Cite
Save
Citations (0)
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective
2020
The Patient: Patient-Centered Outcomes Research
Edouard Louis
Juan Manuel Ramos-Goñi
Jesús Cuervo
Uri Kopylov
Manuel Barreiro-de Acosta
Sara McCartney
Greg Rosenfeld
Dominik Bettenworth
Ailsa Hart
Kerri L. Novak
Xavier Donnet
David Easton
R Saldaña
Katja Protze
Eyal Tzur
Gabriela Alperovich
Francesc Casellas
Show All
Source
Cite
Save
Citations (8)
1